- All sections
- C - Chemistry; metallurgy
- C07H - Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids
- C07H 19/173 - Purine radicals with 2-deoxyribosyl as the saccharide radical
Patent holdings for IPC class C07H 19/173
Total number of patents in this class: 257
10-year publication summary
|
15
|
19
|
17
|
11
|
16
|
18
|
14
|
16
|
9
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1879 |
13 |
| Agilent Technologies, Inc. | 2744 |
10 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
8 |
| Nucana plc | 87 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Illumina Cambridge Limited | 678 |
7 |
| Alios BioPharma, Inc. | 69 |
6 |
| ViiV Healthcare Company | 146 |
6 |
| Janssen Biopharma, Inc. | 52 |
6 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
5 |
| Yamaha Corporation | 4054 |
4 |
| Ajinomoto Co., Inc. | 2337 |
4 |
| Merck Sharp & Dohme Corp. | 2247 |
3 |
| Janssen Pharmaceutica N.V. | 3839 |
3 |
| Massachusetts Institute of Technology | 9795 |
3 |
| CARIS Science, Inc. | 65 |
3 |
| Idenix Pharmaceuticals LLC | 66 |
3 |
| Ionis Pharmaceuticals, Inc. | 776 |
3 |
| Isis Pharmaceuticals, Inc. | 255 |
3 |
| The Regents of the University of Colorado, a body corporate | 2430 |
3 |
| Other owners | 148 |